MedTrace Logo

Effect of an Antiseptic Solution on the Skin Microbiome

NCT05608382 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-11-08

No results posted yet for this study

Summary

The objective of this study is simulate the clinical use of an antiseptic solution in a 24 hour window and the recovery to baseline conditions at 1 month following application. Efficacy will be simulated as the capacity of the material to reduce or clear the skin bacterial population from a representative skin area: the anteromedial forearm.

Conditions

  • Skin Diseases, Infectious

Interventions

OTHER

sterile Phosphate Buffer Saline

control group

OTHER

SGW13

active comparator

Sponsors & Collaborators

  • Center for Innovation and Research Organization

    lead NETWORK

Principal Investigators

  • Javad Parvizi, MD · Center for Innovation and Research Organization

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-07
Primary Completion
2022-03-15
Completion
2022-03-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05608382 on ClinicalTrials.gov